O-GlcNAc in cancer biology

Zhiyuan Ma1, Keith Vosseller

  • 1Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, 245 N 15th St. New College Building Room 10112, Philadelphia, PA, 19102, USA.

Amino Acids
|July 10, 2013
PubMed

Insights

Elevated O-linked β-N-acetylglucosamine (O-GlcNAc) levels are common in cancer, driven by increased glucose and glutamine uptake. This hyper-O-GlcNAcylation contributes to cancer hallmarks and presents a potential therapeutic target.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Biology

Background:

  • O-linked β-N-acetylglucosamine (O-GlcNAc) is a post-translational modification regulating cellular processes, analogous to phosphorylation.
  • O-GlcNAc acts as a nutritional sensor, with levels rising due to increased glucose and glutamine flux.
  • Cancer cells exhibit altered metabolism, notably the Warburg effect, increasing glucose uptake and glutamine utilization.

Purpose of the Study:

  • To investigate the hypothesis linking increased glucose and glutamine uptake in cancer cells to elevated O-GlcNAc levels.
  • To review the established and potential roles of hyper-O-GlcNAcylation in cancer development and progression.
  • To explore the inhibition of hyper-O-GlcNAcylation as a novel cancer therapeutic strategy.

Main Methods:

  • Literature review of studies investigating O-GlcNAcylation in various cancer types.
  • Analysis of the relationship between cancer cell metabolism and O-GlcNAc modification.
  • Synthesis of evidence linking hyper-O-GlcNAcylation to cancer hallmarks.

Main Results:

  • Hyper-O-GlcNAcylation is a prevalent feature across diverse cancer types.
  • Increased O-GlcNAc levels correlate with key cancer characteristics, including proliferation, survival, and metastasis.
  • Evidence suggests a role for O-GlcNAcylation in cancer cell energy metabolism and stress responses.

Conclusions:

  • Hyper-O-GlcNAcylation is a common characteristic of cancer, contributing to its aggressive phenotypes.
  • Targeting O-GlcNAcylation pathways offers a promising avenue for developing new cancer therapies.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...